Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.

نویسندگان

  • Sonal Singh
  • Yoon K Loke
  • John G Spangler
  • Curt D Furberg
چکیده

BACKGROUND There have been postmarketing reports of adverse cardiovascular events associated with the use of varenicline, a widely used smoking cessation drug. We conducted a systematic review and meta-analysis of randomized controlled trials to ascertain the serious adverse cardiovascular effects of varenicline compared with placebo among tobacco users. METHODS We searched MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews, websites of regulatory authorities and registries of clinical trials, with no date or language restrictions, through September 2010 (updated March 2011) for published and unpublished studies. We selected double-blind randomized controlled trials of at least one week's duration involving smokers or people who used smokeless tobacco that reported on cardiovascular events (ischemia, arrhythmia, congestive heart failure, sudden death or cardiovascular-related death) as serious adverse events asociated with the use of varenicline. RESULTS We analyzed data from 14 double-blind randomized controlled trials involving 8216 participants. The trials ranged in duration from 7 to 52 weeks. Varenicline was associated with a significantly increased risk of serious adverse cardiovascular events compared with placebo (1.06% [52/4908] in varenicline group v. 0.82% [27/3308] in placebo group; Peto odds ratio [OR] 1.72, 95% confidence interval [CI] 1.09-2.71; I(2) = 0%). The results of various sensitivity analyses were consistent with those of the main analysis, and a funnel plot showed no publication bias. There were too few deaths to allow meaningful comparisons of mortality. INTERPRETATION Our meta-analysis raises safety concerns about the potential for an increased risk of serious adverse cardiovascular events associated with the use of varenicline among tobacco users.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis

OBJECTIVE To examine the risk of treatment emergent, cardiovascular serious adverse events associated with varenicline use for tobacco cessation. DESIGN Meta-analysis comparing study effects using four summary estimates. DATA SOURCES Medline, Cochrane Library, online clinical trials registries, and reference lists of identified articles. REVIEW METHODS We included randomised controlled tr...

متن کامل

Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

BACKGROUND Varenicline is an efficacious smoking-cessation drug. However, previous meta-analyses provide conflicting results regarding its cardiovascular safety. The publication of several new randomized controlled trials (RCTs) provides an opportunity to reassess this potential adverse drug reaction. METHODS AND RESULTS We searched MEDLINE, EMBASE, and the Cochrane Library for RCTs that comp...

متن کامل

Varenicline for smoking cessation: is it a heartbreaker?

present a meta-analysis assessing the risk of serious adverse cardiovascular events associated with the use of varenicline for smoking cessation. The paper raises additional questions about a drug that has already come under scrutiny by the US Food and Drug Administration for neuropsychiatric safety concerns, and within the past month, the drug has been the focus of another warning regarding an...

متن کامل

Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.

BACKGROUND Stopping smoking is associated with many important improvements in health and quality of life. The use of cessation medications is recommended to increase the likelihood of quitting. However, there is historical and renewed concern that smoking cessation therapies may increase the risk of cardiovascular disease events associated within the quitting period. We aimed to examine whether...

متن کامل

Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis

OBJECTIVE To determine the risk of neuropsychiatric adverse events associated with use of varenicline compared with placebo in randomised controlled trials. DESIGN Systematic review and meta-analysis comparing study effects using two summary estimates in fixed effects models, risk differences, and Peto odds ratios. DATA SOURCES Medline, Embase, PsycINFO, the Cochrane Central Register of Con...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

دوره 183 12  شماره 

صفحات  -

تاریخ انتشار 2011